NewEdge Wealth LLC Has $785,000 Holdings in Chemed Corporation $CHE

NewEdge Wealth LLC lessened its position in Chemed Corporation (NYSE:CHE) by 50.8% in the 1st quarter, according to the company in its most recent filing with the SEC. The institutional investor owned 2,078 shares of the company’s stock after selling 2,143 shares during the quarter. NewEdge Wealth LLC’s holdings in Chemed were worth $785,000 as of its most recent filing with the SEC.

A number of other hedge funds and other institutional investors have also recently added to or reduced their stakes in the company. Commonwealth Equity Services LLC grew its position in Chemed by 3.1% during the 4th quarter. Commonwealth Equity Services LLC now owns 734 shares of the company’s stock worth $314,000 after purchasing an additional 22 shares in the last quarter. Cim LLC lifted its holdings in shares of Chemed by 1.1% in the third quarter. Cim LLC now owns 2,139 shares of the company’s stock valued at $958,000 after purchasing an additional 24 shares in the last quarter. Eukles Asset Management lifted its holdings in shares of Chemed by 0.4% in the fourth quarter. Eukles Asset Management now owns 6,056 shares of the company’s stock valued at $2,591,000 after purchasing an additional 25 shares in the last quarter. Merit Financial Group LLC boosted its position in shares of Chemed by 4.0% in the third quarter. Merit Financial Group LLC now owns 940 shares of the company’s stock worth $421,000 after buying an additional 36 shares during the period. Finally, Deutsche Bank AG boosted its position in shares of Chemed by 1.2% in the fourth quarter. Deutsche Bank AG now owns 2,929 shares of the company’s stock worth $1,253,000 after buying an additional 36 shares during the period. Institutional investors and hedge funds own 95.85% of the company’s stock.

Insiders Place Their Bets

In other news, CEO Kevin J. Mcnamara sold 2,000 shares of the firm’s stock in a transaction dated Friday, May 1st. The stock was sold at an average price of $421.13, for a total transaction of $842,260.00. Following the completion of the sale, the chief executive officer directly owned 90,219 shares of the company’s stock, valued at $37,993,927.47. This trade represents a 2.17% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this hyperlink. Also, Director Andrea R. Lindell sold 1,347 shares of Chemed stock in a transaction dated Tuesday, June 9th. The shares were sold at an average price of $447.33, for a total value of $602,553.51. Following the sale, the director owned 4,578 shares of the company’s stock, valued at approximately $2,047,876.74. This represents a 22.73% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. 3.33% of the stock is currently owned by company insiders.

Wall Street Analysts Forecast Growth

A number of brokerages have recently weighed in on CHE. Bank of America upped their price target on Chemed from $450.00 to $510.00 and gave the company a “neutral” rating in a research report on Thursday, July 9th. Weiss Ratings upgraded Chemed from a “hold (c-)” rating to a “hold (c)” rating in a research report on Friday, July 17th. Royal Bank Of Canada lifted their target price on Chemed from $422.00 to $436.00 and gave the company a “sector perform” rating in a research note on Monday, April 27th. Zacks Research upgraded Chemed from a “strong sell” rating to a “hold” rating in a report on Monday, April 27th. Finally, Wall Street Zen lowered shares of Chemed from a “buy” rating to a “hold” rating in a research report on Monday, June 8th. One equities research analyst has rated the stock with a Buy rating and five have assigned a Hold rating to the stock. According to data from MarketBeat.com, the stock currently has a consensus rating of “Hold” and an average price target of $480.25.

Chemed Trading Down 0.6%

Shares of NYSE:CHE opened at $508.30 on Tuesday. The firm has a fifty day moving average of $459.92 and a two-hundred day moving average of $434.09. The company has a quick ratio of 0.83, a current ratio of 0.85 and a debt-to-equity ratio of 0.11. Chemed Corporation has a 12-month low of $365.20 and a 12-month high of $517.74. The firm has a market capitalization of $6.75 billion, a P/E ratio of 27.70, a price-to-earnings-growth ratio of 1.88 and a beta of 0.52.

Chemed Announces Dividend

The company also recently disclosed a quarterly dividend, which was paid on Tuesday, June 16th. Investors of record on Thursday, May 28th were given a dividend of $0.60 per share. The ex-dividend date of this dividend was Thursday, May 28th. This represents a $2.40 dividend on an annualized basis and a yield of 0.5%. Chemed’s dividend payout ratio (DPR) is presently 13.08%.

About Chemed

Chemed Corporation is a diversified provider of essential home services and healthcare solutions in the United States. Headquartered in Cincinnati, Ohio, the company operates through two principal business segments—Roto-Rooter and Vitas Healthcare. Since its founding in 1974, Chemed has built a reputation for reliability and expertise, serving both residential and commercial customers across a broad range of markets.

The Roto-Rooter segment offers a comprehensive suite of plumbing, drain cleaning and water restoration services.